| Overview |
| bs-9202R-FITC |
| CD300A/C Polyclonal Antibody, FITC Conjugated |
| WB, IF(IHC-P) |
| Human |
| Specifications |
| FITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human CD300A |
| 41-140/299 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 11314 |
| Q9UGN4 |
| Extracellular, Membrane bound |
| CD300A; CMRF35-like molecule 8; CLM-8; CD300 antigen-like family member A; CMRF-35-H9; CMRF35-H9; IRC1/IRC2; Immunoglobulin superfamily member 12;
IgSF12; Inhibitory receptor protein 60; IRp60; NK inhibitory receptor; CMRF35H; CD300C; CMRF35-like molecule 6; CLM-6; CD300 antigen-like family member C; CMRF35-A1; CMRF-35; Immunoglobulin superfamily member 16; IgSF16; CMRF35A1 |
| Inhibitory receptor which may contribute to the down-regulation of cytolytic activity in natural killer (NK) cells, and to the down-regulation of mast cell degranulation. |
| Application Dilution |
| WB |
1:300-5000 |
| IF(IHC-P) |
1:50-200 |
Powered by Bioz